RE:Quote from Q2. SAGDollar wrote: "The Company has initiated a contract with a large health system to improve patient compliance with cancer screening. The details of this contract are confidential between the parties and cannot be disclosed at this time.We have been very open about the fact that we are in discussion with several large health groups and have been anticipating engaging with one or more of them to improve patient compliance with screening for cancer. We are extremely pleased with the direction this relationship has taken and look forward to being able to share the results of the initiative when it is suitable for all parties involved, said James Howard-Tripp, Chairman and CEO of StageZero Life Sciences. Hopefully we can get some clarification on this deal in the near future. The anticipation is real and I think that Oncore deal is just the beginning. Been slowly accumulating this week and hoping that Q3 shows a increase of test volume.. A couple more weeks to go
I could not say this better. Any investor that has been here since the early portion of 2019 is aware of the significant developments StageZero has made. I am confident test numbers , if not already significantly increased, will turn the bend and lead to brighter days for this stock. There is SO MUCH going on that the company has touched on but not fully announced that it is just a matter of time until SP reflects what the company is all about. The technology speaks for itself and the avenue in which we are headed is exciting. StageZero is ganing presence in Europe and North America. Tripp has mentioned that there are a lot of similar deals they are working on. This is something to be excited about. I am optiomistic for solid Q3 numbers and a GREEN holiday season!! Good luck all and happy FRIDAY!!!